The ROE (Return on Equity) of Celon Pharma SA (CLN.WA) is -7.74%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -7.74% |
| 2023-12-31 | -6.31% |
| 2022-12-31 | -8.19% |
| 2021-12-31 | -2.10% |
| 2020-12-31 | -0.27% |
| 2019-12-31 | 2.68% |
| 2018-12-31 | 6.62% |
| 2017-12-31 | 5.82% |
| 2016-12-31 | 9.39% |
| 2015-12-31 | 36.88% |